{
    "root": "9e21f04a-b4b6-45b8-8da3-5955e6aa18a5",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Dexmethylphenidate Hydrochloride",
    "value": "20240731",
    "ingredients": [
        {
            "name": "DEXMETHYLPHENIDATE HYDROCHLORIDE",
            "code": "1678OK0E08"
        },
        {
            "name": "FD&C BLUE NO. 1",
            "code": "H3R47K3TBD"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        }
    ],
    "indications": "dexmethylphenidate hydrochloride tablets indicated treatment attention deficit hyperactivity disorder ( adhd ) [ ( 14 ) ] .",
    "contraindications": "administer orally twice daily , 4 hours apart without food ( 2 ) . patients new methylphenidate : recommend starting dose 5 mg daily ( 2.5 mg twice daily ) ( 2.2 ) . patients currently taking methylphenidate : initiate dexmethylphenidate hydrochloride tablets therapy half ( 1/2 ) current total daily dose methylphenidate ( 2.2 ) . titrate weekly increments 2.5 5 mg maximum 20 mg/day ( 10 mg twice daily ) ( 2.2 ) .",
    "warningsAndPrecautions": "dexmethylphenidate hydrochloride tablets , 2.5 mg blue , round-shaped , convex tablets debossed 91 one side plain side , supplied bottles 100 ndc 27808-091-01 dexmethylphenidate hydrochloride tablets , 5 mg yellow , round-shaped , convex tablets debossed 92 one side plain side , supplied bottles 100 ndc 27808-092-01 dexmethylphenidate hydrochloride tablets , 10 mg white white , round-shaped , convex tablets debossed 93 one side plain side , supplied bottles 100 ndc 27808-093-01 store 20°c 25°c ( 68°f 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure . protect light moisture .",
    "adverseReactions": "hypersensitivity methylphenidate components dexmethylphenidate hydrochloride tablets . hypersensitivity , angioedema anaphylactic reported patients treated methylphenidate [ ( 6.1 ) ] . concomitant treatment monoamine oxidase inhibitors ( maois ) , within 14 days following discontinuation treatment maoi , risk hypertensive crises [ ( 7.1 ) ] .",
    "indications_original": "Dexmethylphenidate hydrochloride tablets are indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) [see Clinical Studies (14)].",
    "contraindications_original": "Administer orally twice daily, 4 hours apart with or without food ( 2 ). For patients new to methylphenidate: Recommend starting dose of 5 mg once daily (2.5 mg twice daily) ( 2.2 ). For patients currently taking methylphenidate: Initiate dexmethylphenidate hydrochloride tablets therapy with half (1/2) the current total daily dose of methylphenidate ( 2.2 ). Titrate weekly in increments of 2.5 to 5 mg to a maximum of 20 mg/day (10 mg twice daily) ( 2.2 ).",
    "warningsAndPrecautions_original": "Dexmethylphenidate Hydrochloride Tablets, 2.5 mg are blue, round-shaped, convex tablets debossed with 91 on one side and plain on the other side, supplied in bottles of 100 NDC 27808-091-01\n                  Dexmethylphenidate Hydrochloride Tablets, 5 mg are yellow, round-shaped, convex tablets debossed with 92 on one side and plain on the other side, supplied in bottles of 100 NDC 27808-092-01\n                  Dexmethylphenidate Hydrochloride Tablets, 10 mg are white to off white, round-shaped, convex tablets debossed with 93 on one side and plain on the other side, supplied in bottles of 100 NDC 27808-093-01\n                  Store at 20°C to 25°C (68°F to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. \n                  Dispense in tight, light-resistant container as defined in the USP, with a child-resistant closure.\n                  Protect from light and moisture.",
    "adverseReactions_original": "Hypersensitivity to methylphenidate or other components of dexmethylphenidate hydrochloride tablets. Hypersensitivity reactions, such as angioedema and anaphylactic reactions have been reported in patients treated with methylphenidate [see Adverse Reactions (6.1)].\n                     Concomitant treatment with monoamine oxidase inhibitors (MAOIs), or within 14 days following discontinuation of treatment with an MAOI, because of the risk of hypertensive crises [see Drug Interactions (7.1)]."
}